Inhibition of GFAT1 activity significantly reduced IFNγ-induced PD-L1 levels in various lung cancer cell lines by suppressing PD-L1 glycosylation and promoting its proteasomal degradation [34]. This evidence concerns the gene CD274 and lung carcinoma.